26-1012m Updates to Medicare Clinical Policies – July 2026
Date: 08/18/26
Review changes to policies and clinical practice guidelines
The medical policies listed in this update were approved by Centene’s National Medicare Quality Improvement Utilization Management Committee and are effective as of July 2026.
For a complete description of the background, criteria, references and coding implications for these Medicare medical policies, go to the Medicare Prior Authorization Medical Clinical Policies page.
Apply the Medicare National Coverage Decisions and applicable Local Coverage Decisions local policies for primary coverage guidance.
Changes to medical policies, effective July 2026
The following are Medicare clinical policies that have been approved for use. The listed policies are effective July 2026.
Updated policies
Policy number and title | Summary of changes |
|---|---|
CC.PP.206 SNF Leveling |
|
MC.CP.MP.249 Allogeneic Hematopoietic Progenitor Cell Therapy |
|
MC.CP.MP.247 Transplant Service Documentation Requirements |
|
MC.CP.MP.185 Skin and Soft Tissue Substitutes |
|
Need help? Contact us
If you have questions regarding the information contained in this update, contact the Health Net Provider Services Center by email, by phone or through the Health Net provider portal. Behavioral health providers can call 844-966-0298.
Provider Services
Line of business | Phone number | |
|---|---|---|
Medicare (Individual & Employer Group) (Wellcare By Health Net) | ||
Medicare Supplement |
This information applies to Physicians and Practitioners, Participating Physician Groups (PPGs), Hospitals, Ancillary Providers, and Behavioral Health Providers.